The Homburg Keratoconus Center (HKC)
ConditionKeratoconus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversität des Saarlandes
About this trial
Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC).
The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.
Eligibility criteria
Qualifiers
All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany.
Disqualifiers
Patients without Keratoconus.
Trial design
Treatments tested in this trial
- Topographic, tomographic and biomechanical analysis.
Treatment groups
5,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Universität des Saarlandes
Lead sponsor
University Hospital, Saarland
Sponsor institution
Source ClinicalTrials.gov